Key result
High NT-proBNP/BNP ratio predicts ~3-fold higher 180-day mortality and HF events in acute HF.
Why the study?
Serum NT-proBNP and BNP levels are rarely evaluated simultaneously in the acute phase of acute heart failure.
Does a high NT-proBNP/BNP ratio predict adverse outcomes in patients with acute heart failure?
Cohort (n=1,002)
Does a high NT-proBNP/BNP ratio predict adverse outcomes in patients with acute heart failure?
A high NT-proBNP/BNP ratio in the acute phase of acute heart failure is associated with non-cardiac conditions like renal dysfunction and inflammation, and independently predicts 180-day mortality and heart failure events.
Answers are grounded in this paper and cite their sources.
May enhance prognostic evaluation in acute HF; leaves open whether ratio-guided strategies improve outcomes.
AIMS: Serum N-terminal pro-brain natriuretic peptide (NT-proBNP) and B-type natriuretic peptide (BNP) levels are rarely evaluated simultaneously in the acute phase of acute heart failure (AHF). METHOD AND RESULTS: A total of 1207 AHF patients were enrolled, and 1002 patients were analysed. Blood samples were collected within 15 min of admission. Patients were divided into two groups according to the median value of the NT-proBNP/BNP ratio [low-NT-proBNP/BNP group (Group L) vs. high-NT-proBNP/BNP group (Group H)]. A multivariate logistic regression model showed that the C-reactive protein level (per 1-mg/dL increase), Controlling Nutrition Status score (per 1-point increase), and estimated glomerular filtration rate (eGFR, per 10-mL/min/1.73 m2 increase) were independently associated with Group H [odds ratio (OR) 1.049, 95% confidence interval (CI) 1.009-1.090, OR 1.219, 95% CI 1.140-1.304, and OR 1.543, 95% CI 1.401-1.698, respectively]. A Kaplan-Meier curve analysis showed that the prognosis was significantly poorer in Group H than in Group L, and a multivariate Cox regression model revealed Group H to be an independent predictor of 180-day mortality [hazard ratio (HR) 3.084, 95% CI 1.838-5.175] and HF events (HR 1.963, 95% CI 1.340-2.876). The same trend in the prognostic impact was significantly observed in the low-BNP (<810 pg/mL, n = 501), high-BNP (≥810 pg/mL, n = 501), and low-eGFR (<60 mL/min/1.73 m2, n = 765) cohorts, and tended to be observed in normal-eGFR (≥60 mL/min/1.73 m2, n = 237) cohort. CONCLUSION: A high NT-proBNP/BNP ratio was associated with a non-cardiac condition (e.g. inflammatory reaction, nutritional status, and renal dysfunction) and is independently associated with adverse outcomes in AHF.
No takes yet. Share an insight, caveat, or question.
Sawatani et al. (2021) conducted a cohort in Acute heart failure (n=1,002). High NT-proBNP/BNP ratio vs. Low NT-proBNP/BNP ratio was evaluated on 180-day mortality (HR 3.084, 95% CI 1.838-5.175). A high NT-proBNP/BNP ratio was an independent predictor of 180-day mortality and heart failure events in patients with acute heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: